phase II trial carboplatin vinblastine treatment advanced squamous cell carcinoma esophagus Cisplatin-containing regimens active treatment esophageal cancer response rates advanced disease Carboplatin toxic cisplatin single agent several responses esophageal tumors role carboplatin esophageal cancer authors chemotherapy-naive patients advanced squamous cell carcinoma esophagus carboplatin vinblastine Carboplatin IV days weeks vinblastine IV day weeks major responses significant renal toxicity mild gastrointestinal toxicity emesis diarrhea Hematologic toxicity severe patients prior radiation therapy RT patients prior RT Grade hematologic toxicity toxic cisplatin-containing regimens carboplatin vinblastine active treatment squamous cell carcinoma esophagus Hematologic toxicity regimen severe patients RT 